BioCentury
ARTICLE | Finance

Trickle-down effect

Smaller caps led biotech in 4Q, but larger mid-caps were big gainers in 2010

January 3, 2011 8:00 AM UTC

Although companies in the $1-$1.9 billion market cap range were the big winners for 2010 with a 28% gain, last quarter saw gains migrate into lower rungs of the market cap ladder.

Small caps with $200-$499 million market caps were up 15%, while those in the $500-$999 million market cap group added 14% in 4Q10...